Preparation and Biological Characterization of Polymeric Micelle Drug Carriers with Intracellular pH-Triggered Drug Release Property: Tumor Permeability, Controlled Subcellular Drug Distribution, and Enhanced in Vivo Antitumor Efficacy
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
A novel intracellular pH-sensitive polymeric micelle drug carrier that controls the systemic, local, and subcellular distributions of pharmacologically active drugs has been developed in this study. The micelles were prepared from self-assembling amphiphilic block copolymers, poly(ethylene glycol)-poly(aspartate hydrazone adriamycin), in which the anticancer drug, adriamycin, was conjugated to the hydrophobic segments through acid-sensitive hydrazone linkers. By this polymer design, the micelles can stably preserve drugs under physiological conditions (pH 7.4) and selectively release them by sensing the intracellular pH decrease in endosomes and lysosomes (pH 5-6). In vitro and in vivo studies show that the micelles have the characteristic properties, such as an intracellular pH-triggered drug release capability, tumor-infiltrating permeability, and effective antitumor activity with extremely low toxicity. The acquired experimental data clearly elucidate that the optimization of both the functional and structural features of polymeric micelles provides a promising formulation not only for the development of intracellular environment-sensitive supramolecular devices for cancer therapeutic applications but also for the future treatment of intractable cancers with limited vasculature.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This same concept was used by Kataoka and colleagues in a series of works leading to development of polymeric micelle NK911, which was evaluated clinically [146, 147].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [147]
In the citing paper
“A study by the Kataoka group showed the development of pH sensitive drug release from PEG-b-P(aspartate hydrazone adriamycin) [147].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [147]
In the citing paper
“This kind of technology can improve drug targeting abilities by only allowing drug release from the micelles under certain external stimuli.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [147]
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Self-citationBlock copolymer micelles for drug delivery: design, characterization and biological significance
Kataoka, K., Harada, A., & Nagasaki, Y. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00124-1 · Cited by 3,506
Self-citationThe dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Amphiphilic block copolymers for drug delivery
Adams, M. L., Lavasanifar, A., & Kwon, G. S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10397 · Cited by 1,078
Trends and Developments in Liposome Drug Delivery Systems
Lian, T., & Ho, R. J. Y. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1023 · Cited by 907
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy
Maeda, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00134-4 · Cited by 662
Development of the polymer micelle carrier system for doxorubicin
Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00341-8 · Cited by 570
Self-citationPolymeric anticancer drugs with pH-controlled activation
Ulbrich, K. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.040 · Cited by 494
Yamamoto, Y., Nagasaki, Y., Kato, Y., Sugiyama, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00451-5 · Cited by 442
Self-citationKwon, G., Suwa, S., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90118-x · Cited by 409
Self-citation3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon
Konerding, M. A., Fait, E., & Gaumann, A. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1809 · Cited by 309
Smart and genetically engineered biomaterials and drug delivery systems
Kopeček, J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00164-7 · Cited by 292
Multicellular spheroids as an in vitro tumor model
Hamilton, G. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00198-0 · Cited by 259
Water soluble polymers in tumor targeted delivery
Kopeček, J., Kopečková, P., Minko, T., Lu, Z.-R., & Peterson, C. M. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00330-3 · Cited by 227
Bae, Y., Fukushima, S., Harada, A., & Kataoka, K. (2003) · Angewandte Chemie · doi:10.1002/ange.200250653 · Cited by 221
Self-citationIshida, T., Kirchmeier, M. J., Moase, E. H., Zalipsky, S., & Allen, T. M. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00409-6 · Cited by 216
Selective Delivery of Adiramycin to a Solid Tumor Using a Polymeric Micelle Carrier System
Yokoyama, M., Okano, T., Sakurai, Y., Fukushima, S., Okamoto, K., & Kataoka, K. (1999) · Journal of Drug Targeting · doi:10.3109/10611869909085500 · Cited by 213
Self-citationUnezaki, S., Maruyama, K., Hosoda, J.-I., Nagae, I., Koyanagi, Y., Nakata, M., Ishida, O., Iwatsuru, M., & Tsuchiya, S. (1996) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04674-1 · Cited by 158
Shiah, J.-G., Dvořák, M., Kopečková, P., Sun, Y., Peterson, C. M., & Kopec̆ek, J. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00374-9 · Cited by 140
Cytoplasmic delivery and nuclear targeting of synthetic macromolecules
Jensen, K. D., Nori, A., Tijerina, M., et al. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00352-8 · Cited by 124
Tsukioka, Y., Matsumura, Y., Hamaguchi, T., 小池浩代, Moriyasu, F., & Kakizoe, T. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01217.x · Cited by 114
Jones, A. T., Gumbleton, M., & Duncan, R. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.07.002 · Cited by 96
Design of a drug delivery system for targeting based on pharmacokinetic consideration
Suzuki, H. I., Nakai, D., Seita, T., et al. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(96)00008-7 · Cited by 30
Research works printed but not linked: 20
- Jain R. K., 2001, Adv. Drug Delivery Rev., 46
- Nishiyama N., 2003, Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 63, 8977−8983
- Lewanski C. R. I., 1999, PEGylated liposomal adriamycin: a review of current and future applications. Pharm. Sci. Technol. Today 2, 473−477
- Kataoka K., 1993, J. Controlled Release, 24
- Ringsdorf H., 1975, J. Polym. Sci. Polym. Symp. 51
- Vasey P. A., 1999, Clin. Cancer Res., 5, 94
- Gordon A. N., 2001, J. Clin. Oncol., 19
- Jain R. K., 1994, Sci. Am., 271, 65
- Takakura Y., 1996, Macromolecular carrier systems for targeted drug delivery: Pharmacokinetic considerations on biodistribution. Pharm. Res. 13, 820−831
- Dvorak H. F., 1998, Am. J. Pathol., 133, 109
- D'souza A. J. M., 2004, J. Pharm. Sci., 93
- Willner D., 1993, (6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin. Bioconjugate Chem. 4, 521−527
- Kaneko T., 1991, New hydrazone derivatives of adriamycin and their immunoconjugates − a correlation between acid stability and cytotoxicity. Bioconjugate Chem. 2, 133−141
- Sutherland R. M., 1988, Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240, 177−184
- Matsumura Y., 1986, A new concept of macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res. 46, 6387−6392
- Jain R. K., 1988, Determinants of tumor blood flow: a review. Cancer Res. 48, 2641−2658
- Baxter L. T., 1994, Physiologically based pharmacokinetic model for specific and nonspecific monoclonal antibodies and fragments in normal tissues and human tumor xenografts in nude mice. Cancer Res. 54, 1517−1528
- Nishiyama N., 2001, Cisplatin-loaded polymer−metal complex micelle with time-modulated decaying property as a novel drug delivery system. Pharmaceut. Res. 18, 1035−1041
- Torchilin V. P., 2003, Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs. P. Natl. Acad. Sci. USA. 100, 6039−6044
- Emanuel N., 1996, Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: Pharmacokinetics and biodistribution in tumor-bearing mice. Pharm. Res. 13, 861−868
Cited by
Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size
Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429
Self-citationA review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Micellar Nanocarriers: Pharmaceutical Perspectives
Torchilin, V. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9132-0 · Cited by 1,910
Metadata
- Authors
- Bae, Y., Nishiyama, N., Fukushima, S., Koyama, H., Yasuhiro, M., & Kataoka, K.
- Affiliations
- National Cancer Center Hospital East (JP)
- Department of Materials Science and Engineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan, Department of Clinical Vascular Regeneration, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan, and Investigative Treatment Division, National Cancer Center Research Institute East, 6-5-1 Kashiwanoha, Kashiwa, Chiba 277-8577, Japan
- Corresponding author
- Kataoka, Kazunori
- Venue
- Bioconjugate Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2004-12-22
- Volume
- 16
- Issue
- 1
- Pages
- 122-130
- ISSN
- 1043-1802 (ISSN-L)
- 1520-4812
- OpenAlex
- W2169187623
- Cited by
- 742
- References
- 23
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 13 · 2023: 22 · 2022: 25 · 2021: 27 · 2020: 41 · 2019: 25 · 2018: 24 · 2017: 43 · 2016: 48 · 2015: 47 · 2014: 60 · 2013: 56 · 2012: 55
- FWCI
- 10.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Bioconjugate Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research Institute
- Japan Science and Technology Corporation
- Core Research for Evolutional Science and Technology
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Keywords
- polymeric micelles, pH-responsive drug release, intracellular pH, doxorubicin, hydrazone linkers, amphiphilic block copolymers, tumor permeability, subcellular drug distribution, antitumor efficacy, drug delivery systems
- MeSH terms
- Animals, Antineoplastic Agents, Doxorubicin, Drug Carriers, Hydrazones, Hydrogen-Ion Concentration, Lysosomes, Micelles, Neoplasms, Experimental, Organ Specificity, Permeability, Polyethylene Glycols, Polymers, Endosomes, Time Factors, Tumor Cells, Cultured, Drug Delivery Systems, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.